Polycythemia Vera Risk Stratification

The biggest MPN updates from ASH 2024Подробнее

How Does Risk Stratification Shape Myelofibrosis Treatment?Подробнее

Risk Stratification in Myelofibrosis: Which Model Should You Use?Подробнее

Use of Cytoreductive Therapy in Patients with Low Risk Polycythemia VeraПодробнее

Managing ET - Dr. Laura MichaelisПодробнее

Limitations of current risk stratification system models for polycythemia veraПодробнее

A new machine learning prediction model for thrombosis risk in polycythemia veraПодробнее

Advances in the risk stratification and treatment of essential thrombocythemiaПодробнее

2021 West Oncology APP | Erythrocytosis – Diagnostic and Therapeutic ConsiderationsПодробнее

Managing Essential Thrombocythemia in 2021 - Dr. Tiziano BarbuiПодробнее

Treatment Options for Polycythemia VeraПодробнее

How would you manage a young man with polycythemia vera and fatigue?Подробнее

Primary Myelofibrosis: Risk StratificationПодробнее

Polycythemia Vera: Risk AssessmentПодробнее

Case 1: Risk Stratification Models for MyelofibrosisПодробнее

Risk Stratification in MyelofibrosisПодробнее

Polycythemia Vera: Treatment Goals & Risk StratificationПодробнее

Risk Stratification for Patients With MyelofibrosisПодробнее

Risk Stratification and the Management of Patients With PVПодробнее

Prognosis and Risk Stratification of MyelofibrosisПодробнее